{"title":"A Review of Current Management Strategies for Hypoactive Sexual Desire Disorder in Postmenopausal Patients.","authors":"Shilpa Darivemula, Camille Moreno, Catalin Ionut Mateas, Katelin Zahn","doi":"10.1097/OGX.0000000000001620","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001620","url":null,"abstract":"<p><strong>Importance: </strong>Hypoactive sexual desire disorder is one of the most prevalent concerns among postmenopausal patients. There is a lack of consolidated information on current treatments, both FDA-approved and off-label, risks, and benefits for routine clinical use.</p><p><strong>Objective: </strong>To review current evidence on diagnosis and treatments for HSDD in the postmenopausal population and to offer practical advice for use in clinical counseling.</p><p><strong>Evidence acquisition: </strong>A PubMed search was performed using appropriate keywords to identify and evaluate journal articles focused on this subject. Current guidelines and recommendations were obtained from the websites of national and international organizations.</p><p><strong>Results: </strong>There is a dearth of information on current and practical screening tools, medical treatments, and nonmedical treatment options specifically designed and validated for the postmenopausal population. In addition, studies involving postmenopausal patients with HSDD are limited in diversity of enrollment and, therefore, generalizability to the diverse US population.</p><p><strong>Conclusions and relevance: </strong>Health care professionals providing care for postmenopausal patients with HSDD should utilize screening tools to identify HSDD and approach their clinical counseling with a patient-centered focus. This counseling should include resources for supplies, risks, and benefits of each treatment option, and a review of any financial barriers to accessing treatments. This review suggests best practices to improve diagnosis, treatment, and counseling around HSDD specifically in this vulnerable population.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 11","pages":"549-559"},"PeriodicalIF":4.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Expanding Role of the Physician Informaticist in Obstetrics and Gynecology: Bridging Digital Innovation and Clinical Care.","authors":"Annessa Kernberg, Tina A Nguyen","doi":"10.1097/OGX.0000000000001619","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001619","url":null,"abstract":"<p><strong>Importance: </strong>Digital transformation has fundamentally reshaped obstetrics and gynecology (OB/GYN). Electronic health records (EHRs), clinical decision support systems (CDSS), telehealth, and artificial intelligence (AI) are now central to care delivery. Physician informaticists uniquely bridge clinical expertise with health information technology to optimize safety, quality, and equity in women's health.</p><p><strong>Objective: </strong>To synthesize current evidence regarding the roles, impact, and competencies of physician informaticists in OB/GYN.</p><p><strong>Evidence acquisition: </strong>Literature from 2019 to 2026 was reviewed, including studies on clinical informatics, AI-augmented CDSS, predictive modeling, and digital patient communication in OB/GYN.</p><p><strong>Results: </strong>Physician informaticists improve workflow efficiency, reduce errors, and enhance guideline adherence. In OB/GYN, informatics leadership supports these goals through CDSS, predictive modeling, and digital patient communication. AI-driven CDSS demonstrate growing utility in pregnancy care, including diagnostic support, risk prediction, and therapeutic recommendations, though implementation gaps and bias remain. Machine learning models show promise in predicting obstetric interventions such as labor induction. In addition, large language models (LLMs) can generate accurate and relevant responses to gynecologic patient questions, though limitations include readability and safety oversight.</p><p><strong>Conclusions: </strong>Physician informaticists are essential to modern OB/GYN practice, particularly as AI and predictive analytics become embedded in care delivery. While strong evidence supports informatics interventions in safety and quality improvement, emerging AI applications require rigorous validation, governance, and equity-focused implementation.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 11","pages":"541-548"},"PeriodicalIF":4.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sebastiaan W A Nij Bijvank Md, Johannes J Duvekot Md PhD
{"title":"Nicardipine for the Treatment of Severe Hypertension in Pregnancy: An Updated Review.","authors":"Sebastiaan W A Nij Bijvank Md, Johannes J Duvekot Md PhD","doi":"10.1097/OGX.0000000000001658","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001658","url":null,"abstract":"<p><strong>Importance: </strong>To reduce morbidity (and mortality) due to severe hypertension in pregnancy by searching the most effective and safe treatment.</p><p><strong>Objective: </strong>Update of our review (2010) on efficacy and safety of intravenous nicardipine for treatment of severe hypertension in pregnancy.</p><p><strong>Evidence acquisition: </strong>Articles were identified through electronic databases (Medline and Cochrane). Date of search: January 2010 to September 2025. Following search terms were used: pregnancy, severe hypertension, and nicardipine. Included women had chronic or gestational hypertension with or without marked proteinuria. Primary outcomes: reduction of systolic/diastolic and/or mean arterial pressure, time needed to target blood pressure, severe maternal (hypotension, tachycardia), severe fetal (CTG abnormalities needing direct intervention), and side effects.</p><p><strong>Results: </strong>Five studies were added to the original review. Results of 1125 patients were available. All women had a significant reduction of both diastolic and systolic blood pressures. Treatment resulted in a success rate of 99.2%. Time until successful treatment was short with a median of 37 minutes. Comparison of nicardipine versus labetalol showed a significantly greater reduction of blood pressure and a shorter time to success for nicardipine. No severe maternal or fetal side effects were recorded.</p><p><strong>Conclusions and relevance: </strong>This updated review strengthens our conclusions of 2010: nicardipine is a very effective therapy for the treatment of severe hypertension in pregnancy and may be a better alternative to other available treatment options. More studies are needed to provide safety aspects of nicardipine compared with other agents. Apparently, this is dependent on political choices on the distribution of budgetary scarcity.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 11","pages":"560-566"},"PeriodicalIF":4.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brighton S Goodhue, Sky E Dainty, Neeta Vora, Jeffrey A Kuller, Matthew R Grace
{"title":"Cell-Free DNA Screening for Single-Gene Disorders: Erratum.","authors":"Brighton S Goodhue, Sky E Dainty, Neeta Vora, Jeffrey A Kuller, Matthew R Grace","doi":"10.1097/OGX.0000000000001657","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001657","url":null,"abstract":"","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 10","pages":"512"},"PeriodicalIF":4.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inclusive Fertility Treatment: Reproductive Options for LGBTQ+ Families.","authors":"Esther Wu, Danielle Strom, Robert A Roman","doi":"10.1097/OGX.0000000000001600","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001600","url":null,"abstract":"<p><strong>Importance: </strong>As access to and research in LGBTQ+ family building continue to expand, clinicians must be familiar with the evolving literature to effectively counsel patients regarding reproductive options. Unique considerations in this population include selection of donor gametes, comparative efficacy of fertility treatments, use of third-party reproduction, and appropriate timing of cessation and resumption of gender-affirming hormone therapy (GAHT). National organizations, including the American Society for Reproductive Medicine (ASRM), have published guidance addressing the distinct needs of LGBTQ+ individuals pursuing family building.</p><p><strong>Objective: </strong>To review available family-building options for LGBTQ+ individuals and their partners in the United States, with a focus on fertility treatments and assisted reproductive technology (ART), and to highlight barriers to care encountered by this population.</p><p><strong>Evidence acquisition: </strong>A narrative review of obstetrics and gynecology- and LGBTQ-focused research articles and clinical practice guidelines was conducted. Literature searches using relevant keywords related to LGBTQ+ individuals, same-sex couples, transgender and gender-diverse populations, and family building were performed in PubMed and limited to English-language publications.</p><p><strong>Results: </strong>Multiple fertility and ART options exist for LGBTQ+ individuals desiring a genetic connection with their children. Same-sex female couples may pursue donor intrauterine insemination (IUI), in vitro fertilization (IVF), or reciprocal IVF, with pregnancy outcomes comparable to or exceeding those of heterosexual counterparts. Same-sex male couples commonly pursue gestational surrogacy using donor oocytes and a gestational carrier. Transgender and gender-diverse individuals may utilize similar fertility treatments, including IUI, IVF, fertility preservation, and third-party reproduction, with additional considerations related to GAHT.</p><p><strong>Conclusions and relevance: </strong>LGBTQ+ individuals have a broad range of family-building options. Increasing clinician familiarity with these pathways is essential to provide informed counseling, mitigate barriers to care, and facilitate timely referral to fertility specialists.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 10","pages":"505-511"},"PeriodicalIF":4.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sonia Giouleka, Ioannis Tsakiridis, Georgios Michos, Eirini Boureka, Sofoklis Stavros, Anastasios Potiris, Apostolos Mamopoulos, Ioannis Kalogiannidis, Petya Chaveeva, Themistoklis Dagklis
{"title":"Management of Monochorionic Twins: A Comprehensive Review of Major Guidelines.","authors":"Sonia Giouleka, Ioannis Tsakiridis, Georgios Michos, Eirini Boureka, Sofoklis Stavros, Anastasios Potiris, Apostolos Mamopoulos, Ioannis Kalogiannidis, Petya Chaveeva, Themistoklis Dagklis","doi":"10.1097/OGX.0000000000001599","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001599","url":null,"abstract":"<p><strong>Importance: </strong>Monochorionic (MC) twin pregnancies are at risk of unique fetal and obstetric complications, which require increased surveillance and specific interventions to minimize the associated neonatal morbidity and mortality.</p><p><strong>Objective: </strong>This review aimed to evaluate and compare the most recently published influential guidelines on the management of monochorionic twin pregnancies.</p><p><strong>Evidence acquisition: </strong>A comparative review of guidelines from the Royal College of Obstetricians and Gynaecologists (RCOG), the Society of Obstetricians and Gynaecologists of Canada (SOGC), the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), the International Federation of Gynecology and Obstetrics (FIGO), and the International Society of Ultrasound in Obstetrics and Gynaecology (ISUOG) was carried out.</p><p><strong>Results: </strong>All the reviewed guidelines recommend the determination of chorionicity and amnionicity in the first trimester, along with the precise labeling of the twins and confirmation of the gestational age based on the crown-rump length of the larger twin or the dates of assisted reproductive techniques. They also encourage the performance of aneuploidy screening during the first trimester, using either a combined nuchal translucency and biochemical markers test or cfDNA. A detailed anatomy scan is recommended, with emphasis on the fetal cardiac assessment. There is agreement on the recommended ultrasonographic surveillance protocol, the diagnostic criteria of TTTS, TAPS, and TRAP, the optimal timing of delivery in case of uncomplicated MC twins, and the need for earlier delivery in case of complications or MCMA twins. All the reviewed medical societies provide similar recommendations regarding the management of pregnancies complicated by TTTS, TAPS, discordant fetal anomaly, and demise of one co-twin. Minor discrepancies were identified regarding the diagnosis and management of sFGR, the routine assessment of cervical length, as well as the first-line aneuploidy screening method.</p><p><strong>Conclusions: </strong>Multiple pregnancies pose significant maternal, fetal, and obstetric risks compared with singleton pregnancies, with MC twins being at the highest risk of adverse perinatal outcomes, particularly in the absence of increased surveillance or therapeutic interventions. The development and implementation of consistent international evidence-based practice guidelines for the prompt diagnosis and management of MC twin pregnancies and their associated complications may contribute to more favorable outcomes.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 10","pages":"491-504"},"PeriodicalIF":4.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lindsey B Sward, Amy M Phillips, Anna C Thurlby, Jasmine Cooper, Tommy W Wagner, Everett F Magann
{"title":"Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NALFD) in Pregnancy: A Narrative Review.","authors":"Lindsey B Sward, Amy M Phillips, Anna C Thurlby, Jasmine Cooper, Tommy W Wagner, Everett F Magann","doi":"10.1097/OGX.0000000000001579","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001579","url":null,"abstract":"<p><strong>Importance: </strong>Nonalcoholic steatohepatitis/nonalcoholic fatty liver disease (NASH/NALFD) is coupled with a substantial risk of morbidity and mortality and is increasingly identified as a comorbidity in pregnancy. Information about the effect of NAFLD on pregnancy and perinatal outcomes is incomplete.</p><p><strong>Objectives: </strong>This review examines the etiology, pathophysiology, risk factors, diagnosis, management, maternal and perinatal outcomes, and recurrence risk in pregnancies complicated by NASH/NALFD.</p><p><strong>Evidence acquisition: </strong>Electronic databases searched were (PUBMED and Embase). The search terms used were \"pregnancy\" OR \"perinatal care\" AND \"nonalcoholic steatohepatitis\" OR \"NASH\" OR \"NALFD\" OR \"nonalcoholic fatty liver disease. The search was limited to the English language, but not to the years searched.</p><p><strong>Results: </strong>There were 515 abstracts identified, of which 73 are the basis of this review. NAFLD is seen as the hepatic manifestation of the metabolic syndrome (abdominal obesity, low HDL cholesterol, elevated fasting glucose, overweight/obese body mass index). The overall prevalence among pregnant women with NAFLD from a large prospective study was 14%. Consistent risk factors of NAFLD in pregnancy include prepregnancy obesity, metabolic syndrome, type 2 diabetes, and polycystic ovarian syndrome. Diagnosis is confirmed by steatosis, ballooning, and inflammation on liver biopsy. Treatment is primarily weight reduction and lifestyle modifications. Maternal complications during pregnancy include gestational diabetes, hypertension, cesarean delivery, postpartum hemorrhage, and congestive heart failure. Fetal complications include spontaneous abortion, fetal growth restriction, large-for-gestational-age neonates, and preterm birth.</p><p><strong>Conclusions: </strong>The increase in NAFLD in pregnancy parallels the increase in maternal obesity and metabolic syndrome. Unfavorable pregnancy outcomes include hypertensive disorders of pregnancy, cesarean delivery, postpartum hemorrhage, congestive heart failure, early pregnancy losses, fetal growth restriction, large neonates, and preterm deliveries. Management primarily consists of weight reduction and lifestyle modifications.</p><p><strong>Relevance: </strong>The escalating rate of overweight or obese women who become pregnant and the neonates of these women, both of which are being diagnosed with NAFLD at an increasing rate, is very worrisome. Particularly since our only current treatment is weight reduction and lifestyle modifications, neither of which, to date, has been very successful in maternal weight reduction.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 9","pages":"449-457"},"PeriodicalIF":4.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrea Gorodezky, Sara I Jones, Jeffrey A Kuller, Sarah K Dotters-Katz, Matthew R Grace
{"title":"The Impact of Wilson Disease on the Female Reproductive System.","authors":"Andrea Gorodezky, Sara I Jones, Jeffrey A Kuller, Sarah K Dotters-Katz, Matthew R Grace","doi":"10.1097/OGX.0000000000001578","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001578","url":null,"abstract":"<p><strong>Importance: </strong>Wilson disease (WD) is a rare genetic disorder that results in an accumulation of excess copper and can severely impact quality of life through its effects on numerous organ systems. Less is understood, however, about how WD alters the female reproductive system, where its impact is suspected to be wide-ranging.</p><p><strong>Objective: </strong>To provide an overview of the impact of WD on various aspects of women's health, including menstruation, fertility, pregnancy, and menopause. Key considerations and recommendations for management are highlighted throughout.</p><p><strong>Evidence acquisition: </strong>Articles were obtained through a literature search of PubMed and Google Scholar.</p><p><strong>Results: </strong>WD impacts multiple aspects of women's health. WD may lead to delayed menarche, amenorrhea, and decreased fertility. Timely treatment can largely diminish these effects. WD's neuropsychiatric and hepatic manifestations, along with its respective medical therapy, may lead to higher rates of sexual dysfunction. There are many safe contraceptive options available for patients with WD. Treatment should be continued throughout pregnancy, although there are no conclusive guidelines. The safety of breastfeeding in patients with WD is under-studied. Lastly, WD is not known to directly impact menopause.</p><p><strong>Conclusions: </strong>Complete care of female patients with WD requires consideration of its impact on various stages of the reproductive lifespan. Thus, an interdisciplinary team is an important component of optimizing care. Primary research in the field remains limited, and further studies are necessary to advance evidence-based care.</p><p><strong>Relevance: </strong>This review highlights the latest evidence regarding how WD affects women's health, along with recommendations for best management.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 9","pages":"443-448"},"PeriodicalIF":4.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sara I Jones, Felix R De Bie, Rachel L Wood, Brita K Boyd, Ryan M Antiel, Jeffrey A Kuller
{"title":"Congenital Diaphragmatic Hernia: A Review of Evaluation and Management.","authors":"Sara I Jones, Felix R De Bie, Rachel L Wood, Brita K Boyd, Ryan M Antiel, Jeffrey A Kuller","doi":"10.1097/OGX.0000000000001588","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001588","url":null,"abstract":"<p><strong>Importance: </strong>Congenital diaphragmatic hernia (CDH) has significant implications for neonatal morbidity and mortality that require multidisciplinary antenatal and post-delivery care.</p><p><strong>Objective: </strong>To describe the current evidence behind the etiology, diagnosis, and management of congenital diaphragmatic hernia, with specific attention to risk stratification, multidisciplinary management strategies, fetal cardiovascular morbidity, genetic evaluation, and surgical management of this condition.</p><p><strong>Evidence acquisition: </strong>Evidence for this review was acquired through a comprehensive search of PubMed-indexed articles using MeSH terms and text to search for concepts related to \"Congenital Diaphragmatic Hernia,\" \"prenatal diagnosis,\" \"genetics,\" \"fetal therapy,\" \"embryology,\" \"extracorporeal life support,\" \"surgical management,\" \"prognosis,\" and their synonyms.</p><p><strong>Results: </strong>Neonatal survival and long-term outcomes vary by severity of CDH and are primarily driven by the development of pulmonary hypoplasia. Various factors, including the amount of measurable fetal lung tissue, stomach and liver position, side (right vs. left) of CDH, underlying genetic diagnoses, and concomitant anomalies (especially cardiac) contribute to the prognosis in the setting of prenatally diagnosed CDH. Given the need for multidisciplinary care coordination and anticipated postnatal surgical management, patients identified with a CDH in their fetus should be referred to a tertiary center for antenatal surveillance and delivery.</p><p><strong>Conclusions and relevance: </strong>CDH is associated with high morbidity and mortality; continued attention to prenatal diagnosis and multidisciplinary management of this condition may help improve the quality of life for affected patients.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 9","pages":"458-463"},"PeriodicalIF":4.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preoperative Hyperglycemia in GYN Surgery: Perioperative Considerations.","authors":"Tahireh Markert, Samantha Kaplan, Alison Weidner, Annika Sinha","doi":"10.1097/OGX.0000000000001577","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001577","url":null,"abstract":"<p><strong>Importance: </strong>There is not clear consensus on perioperative A1C goals in gynecologic (GYN) surgery.</p><p><strong>Objective: </strong>To review current literature regarding glycemic control and postoperative outcomes for major GYN surgery for benign, urogynecologic, or oncologic indications.</p><p><strong>Evidence acquisition: </strong>Review conducted using the following databases: MEDLINE via PubMed, Embase via Elsevier, and the Web of Science Core Collection via Clarivate. Included studies were peer-reviewed articles published (1990-current) that examined postoperative complications following major GYN surgery, including hysterectomy, myomectomy, debulking, adnexal mass, vulvectomy, sacrocolpopexy, and percutaneous neurostimulator implants. Data extracted included study design, demographic data, type of surgery, complications, and measure of glycemic control.</p><p><strong>Results: </strong>Of 698 studies, 14 were included: 4 in benign GYN literature, 3 in urogynecology literature, and 7 in GYN oncology literature. In benign GYN literature, hemoglobin A1C values greater than 9% were directly associated with surgical site infection (SSI). In urogynecology, A1C greater than 8% was associated with increased urinary tract infections, wound separation, midurethral sling failure, and composite complications. Finally, in GYN oncology, an A1C greater than or equal to 7% was associated with decreased recurrence-free survival and cancer-specific survival. Preoperative glucose above 110 mg/dL was associated with increased risk of deep vein thrombosis (DVT) in ovarian cancer patients and risk of SSI in endometrial cancer patients.</p><p><strong>Conclusions and relevance: </strong>High preoperative A1C is associated with worse postoperative outcomes in the setting of major GYN surgeries. Here we provide guidelines by GYN subspecialty.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"81 8","pages":"406-413"},"PeriodicalIF":4.7,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148685370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}